During the past decade, Chattanooga Research & Medicine, PLLC conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chattanooga Research & Medicine, PLLC" #1 sponsor was "Arena Pharmaceuticals" with 1 trials, followed by "AstraZeneca" with 1 trials sponsored, "Ionis Pharmaceuticals, Inc." with 1 trials sponsored, "Kowa Research Institute, Inc." with 1 trials sponsored and "NewAmsterdam Pharma" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chattanooga Research & Medicine, PLLC" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Chattanooga Research & Medicine, PLLC" are "Atherosclerotic Cardiovascular Disease" (1 trials), "Hypertension" (1 trials), "Irritable Bowel Syndrome" (1 trials), "Severe Hypertriglyceridemia" (1 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "Chattanooga Research & Medicine, PLLC" in a lesser frequency.

Most popular intervention types in "Chattanooga Research & Medicine, PLLC" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Dapagliflozin" (1 trials), "Fenofibrate" (1 trials), "IONIS-AGT-LRx" (1 trials) and "K-877" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chattanooga Research & Medicine, PLLC" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Chattanooga Research & Medicine, PLLC". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Chattanooga Research & Medicine, PLLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Chattanooga Research & Medicine, PLLC, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".